KPMG in Romania announced the appointment of three new partners: Bogdan Vlad and Nicoleta Rusu in the Audit Department, and Robert Maxim in Advisory.
Bogdan Vlad, Audit Partner, has been with KPMG for twenty years and his promotion to the partnership is a result of the ‘considerable experience he has gained throughout his career, in audit and quality and risk management’.
“It is a privilege to join the partnership of KPMG in Romania. In times of change, our risk management and audit professionals assist business leaders dealing with complex issues to drive strategic decisions. I will continue to build out our capabilities so we remain the clear choice among professional services firms,” he said.
Nicoleta Rusu, Audit Partner, is an experienced audit professional, who has been part of KPMG in Romania’s Audit department for more than 20 years. During this time, she has conducted audits covering numerous sectors, including Telecom, General Manufacturing, Retail and Oil&Gas. She has also played an active part in various local and international KPMG Audit Quality and Innovation projects.
“Ever since I joined the firm as a junior staff member over 20 years ago I have had great respect for the leadership style at KPMG. So it’s a privilege and a great responsibility to take on as Partner in these challenging times. The expectations are high from our clients, our people, markets and regulators-but it is these challenges that offer the best opportunities for growth. I am looking forward to turning these opportunities into success stories and continuing to provide our clients with services that live up to our values”, she said.
Robert Maxim, Advisory Partner, joins the Partnership as a result of the recent integration of Ensight Management Solutions into KPMG in Romania. Formerly Partner at Ensight, Robert has considerable experience of offering consultancy services to the Romanian market. During his career he has worked with clients in various industries, such as financial services, retail, energy, real-estate, healthcare and pharma.
